AKOS B018304 is a potent inhibitor of chikungunya virus with low micro molar activity.
Akt Inhibitor VIII is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity (IC50 = 58 nM, 210 nM, and 2.12 μM; respectively).
Akt Inhibitor VIII is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity (IC50 = 58 nM, 210 nM, and 2.12 μM; respectively).
Akt Inhibitor VIII is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity (IC50 = 58 nM, 210 nM, and 2.12 μM; respectively).
Akt Inhibitor VIII is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity (IC50 = 58 nM, 210 nM, and 2.12 μM; respectively).
AL 082D06 is a selective non-steroidal glucocorticoid receptor (GR) antagonist with Ki of 210 nM. There was no significant binding affinity for corticosteroids, androgens, estrogens and progesterone.
AL 082D06 is a selective non-steroidal glucocorticoid receptor (GR) antagonist with Ki of 210 nM. There was no significant binding affinity for corticosteroids, androgens, estrogens and progesterone.
AL 082D06 is a selective non-steroidal glucocorticoid receptor (GR) antagonist with Ki of 210 nM. There was no significant binding affinity for corticosteroids, androgens, estrogens and progesterone.
AL 082D06 is a selective non-steroidal glucocorticoid receptor (GR) antagonist with Ki of 210 nM. There was no significant binding affinity for corticosteroids, androgens, estrogens and progesterone.
Alagebrium Chloride, also known as ALT711, is an advanced glycation end product (AGE) inhibitor.